Tang capital bought 5,99000 stocks of affy in march
May be you guys know kevin tang he is one of the brightest biotechnology investors. You may or may not know that he was a biotechnology analyst on Wall Street before he became a money manager. This gives him a broader exposure and understanding of how to maximize shareholder value than managers who come from the science or finance side. In biopharma I Follow his stocks.